Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II
<i>Background:</i> Type 2 diabetes (T2D) cardiovascular disease (CVD) risk assessment has limitations. The aim of this study was to develop a risk equation adding heart failure (HF) to conventional major adverse cardiovascular events (MACE, myocardial infarction, stroke, and CVD death) a...
Main Authors: | Wendy A. Davis, Valentina Hellbusch, Michael L. Hunter, David G. Bruce, Timothy M. E. Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/5/1428 |
Similar Items
-
Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
by: Jocelyn J. Drinkwater, et al.
Published: (2020-03-01) -
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study
by: Wendy A. Davis, et al.
Published: (2023-09-01) -
Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Database of Australia
by: Nishant Nundlall, et al.
Published: (2021-09-01) -
The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study.
by: Kirsten E Peters, et al.
Published: (2013-01-01) -
Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study
by: Wendy A. Davis, et al.
Published: (2022-12-01)